[go: up one dir, main page]

FR2613624B1 - Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines - Google Patents

Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines

Info

Publication number
FR2613624B1
FR2613624B1 FR8705110A FR8705110A FR2613624B1 FR 2613624 B1 FR2613624 B1 FR 2613624B1 FR 8705110 A FR8705110 A FR 8705110A FR 8705110 A FR8705110 A FR 8705110A FR 2613624 B1 FR2613624 B1 FR 2613624B1
Authority
FR
France
Prior art keywords
lactamines
reducing
effects
pharmaceutical composition
oral administrative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8705110A
Other languages
English (en)
Other versions
FR2613624A1 (fr
Inventor
Antoine Andremont
Florence Leonard
Roger Labia
Cyrille Tancrede
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Gustave Roussy (IGR)
Original Assignee
Institut Gustave Roussy (IGR)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Gustave Roussy (IGR) filed Critical Institut Gustave Roussy (IGR)
Priority to FR8705110A priority Critical patent/FR2613624B1/fr
Priority to ZA882426A priority patent/ZA882426B/xx
Priority to AU15786/88A priority patent/AU604117B2/en
Priority to JP63503346A priority patent/JPH01503537A/ja
Priority to PT87190A priority patent/PT87190B/pt
Priority to PCT/FR1988/000172 priority patent/WO1988007865A1/fr
Priority to EP88903277A priority patent/EP0309532A1/fr
Publication of FR2613624A1 publication Critical patent/FR2613624A1/fr
Priority to OA59487A priority patent/OA09023A/fr
Priority to DK685988A priority patent/DK685988A/da
Application granted granted Critical
Publication of FR2613624B1 publication Critical patent/FR2613624B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8705110A 1987-04-10 1987-04-10 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines Expired - Lifetime FR2613624B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR8705110A FR2613624B1 (fr) 1987-04-10 1987-04-10 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines
ZA882426A ZA882426B (en) 1987-04-10 1988-04-07 Orally administrable therapeutic compositions for the reduction of beta-lactamines undesirable actions
JP63503346A JPH01503537A (ja) 1987-04-10 1988-04-08 β‐ラクタミン類の効果を減少させるための、経口投与可能な治療用組成物
PT87190A PT87190B (pt) 1987-04-10 1988-04-08 Processo para a preparacao de composicoes farmaceuticas para a reducao dos efeitos indesejaveis das beta-lactaminas
AU15786/88A AU604117B2 (en) 1987-04-10 1988-04-08 Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
PCT/FR1988/000172 WO1988007865A1 (fr) 1987-04-10 1988-04-08 COMPOSITION PHARMACEUTIQUE, ADMINISTRABLE PAR VOIE ORALE, DESTINEE A REDUIRE LES EFFETS DES ß-LACTAMINES
EP88903277A EP0309532A1 (fr) 1987-04-10 1988-04-08 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des -lactamines
OA59487A OA09023A (fr) 1987-04-10 1988-12-09 Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
DK685988A DK685988A (da) 1987-04-10 1988-12-09 Peroralt farmaceutisk praeparat til reduktion af beta-lactaminers virkning

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705110A FR2613624B1 (fr) 1987-04-10 1987-04-10 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines

Publications (2)

Publication Number Publication Date
FR2613624A1 FR2613624A1 (fr) 1988-10-14
FR2613624B1 true FR2613624B1 (fr) 1990-11-23

Family

ID=9350003

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8705110A Expired - Lifetime FR2613624B1 (fr) 1987-04-10 1987-04-10 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines

Country Status (8)

Country Link
EP (1) EP0309532A1 (fr)
JP (1) JPH01503537A (fr)
AU (1) AU604117B2 (fr)
FR (1) FR2613624B1 (fr)
OA (1) OA09023A (fr)
PT (1) PT87190B (fr)
WO (1) WO1988007865A1 (fr)
ZA (1) ZA882426B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI920206A0 (fi) * 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
FI20105572A0 (fi) 2010-05-24 2010-05-24 Prevab R Lcc Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN106163546B (zh) 2014-04-17 2021-02-19 合成生物制品有限公司 具有改进的治疗性质的β-内酰胺酶
EP3186379B1 (fr) 2014-08-28 2020-04-08 Synthetic Biologics, Inc. Production de bêta-lactamase à partir d'e-coli
EP3204495B1 (fr) 2014-10-08 2020-04-22 Synthetic Biologics, Inc. Formulations de bêta-lactamase et utilisations de celles-ci
HUE035569T2 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd Bacteroides thetaiotaomicron strain and its use in reducing inflammation
KR20170091157A (ko) 2014-12-23 2017-08-08 4디 파마 리서치 리미티드 피린 폴리펩티드 및 면역 조정
EP3236993B1 (fr) 2014-12-23 2023-09-13 Theriva Biologics, Inc. Méthodes et compositions pour inhiber ou prévenir les effets néfastes des antibiotiques oraux
JP6810697B2 (ja) 2015-02-23 2021-01-13 シンセティック・バイオロジクス・インコーポレイテッド 腸内マイクロバイオームの保護のために抗生物質と共に使用するカルバペネマーゼ
WO2016144856A1 (fr) 2015-03-06 2016-09-15 Synthetic Biologics, Inc. Dosage de beta-lactamase sûr et efficace pour la protection du microbiome
HUE045413T2 (hu) 2015-06-15 2019-12-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
ES2753779T3 (es) 2015-06-15 2020-04-14 4D Pharma Res Ltd Blautia stercosis y wexlerae para la utilización en el tratamiento de enfermedades inflamatorias y autoinmunes
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
SG11201807195VA (en) 2016-03-04 2018-09-27 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
HUE054164T2 (hu) 2017-05-22 2021-08-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
ES2855701T3 (es) 2017-06-14 2021-09-24 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物

Also Published As

Publication number Publication date
ZA882426B (en) 1988-09-28
WO1988007865A1 (fr) 1988-10-20
JPH01503537A (ja) 1989-11-30
AU1578688A (en) 1988-11-04
PT87190A (pt) 1988-05-01
PT87190B (pt) 1992-08-31
FR2613624A1 (fr) 1988-10-14
OA09023A (fr) 1991-03-31
AU604117B2 (en) 1990-12-06
EP0309532A1 (fr) 1989-04-05

Similar Documents

Publication Publication Date Title
FR2613624B1 (fr) Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
FI862479L (fi) Oral farmaceutisk komposition.
EP0302900A4 (fr) Compositions pharmaceutiques avec dissimulation du gout.
FI883785A0 (fi) Kapsel foer farmaceutiskt verksamt inhaleringsaemne i ett laekemedel.
IT1210666B (it) Preparato farmaceutico ad assorbimento percutaneo per il trattamento di angina pectoris
NO862189D0 (no) Fremgangsmaate for overfoering av antimikrobiell virkning fra akrylforbindelser.
KR890701101A (ko) 제약학적 조성물
FI903759A7 (fi) Oraalisesti annettava N-asetyyli-kysteiiniä sisältävä farmaseuttinen koostumus
EP0282020A3 (en) Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
DE3852599D1 (de) Orale Zusammensetzungen.
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
FI910088L (fi) Oral farmaceutisk komposition.
FR2480603B1 (fr) Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
DE3267248D1 (en) Retard oral pharmaceutical compositions
DK585183A (da) 14-acyloxy-2'-halogenanthracycliner til brug som anticancer-antibiotika
GB2194733B (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs
MX11584A (es) Composiciones farmaceuticas
OA06135A (fr) Composition pharmaceutique administrable par voie orale.
FR2588264B1 (fr) Composition desinfectante pour voie aerienne
EP0300036A4 (fr) Compositions pharmaceutiques a base de vasopressine.
FR2586351B1 (fr) Composition pharmaceutique a base de peroxodiphosphate pour l'inactivation d'endotoxines bacteriennes
NZ221549A (en) Penicillin derivatives & pharmaceutical compositions

Legal Events

Date Code Title Description
ST Notification of lapse